Seres Therapeutics, Inc. (1S9.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR

Add to watchlist

0.9288

-0.0270

(-2.82%)

As of 08:47AM CEST. Market open.

Loading interactive chart...

Simply Wall St.
Seres Therapeutics First Quarter 2024 Earnings: US$0.28 loss per share (vs US$0.56 loss in 1Q 2023)
Seres Therapeutics ( NASDAQ:MCRB ) First Quarter 2024 Results Key Financial Results Net loss: US$40.1m (loss narrowed...
GuruFocus.com
Seres Therapeutics Inc (MCRB) Q1 2024 Earnings Call Transcript Highlights: Strategic Insights ...
Unveiling key financial results and strategic directions, including the impactful launch of VOWST and promising developments in SER-155.
GuruFocus.com
Seres Therapeutics Reports Q1 2024 Earnings: Surpasses Revenue Estimates
Financial Highlights and Strategic Updates